Patent · US Active

Inhibitors of HCV NS5A

US8921369B2 · kind B2 · utility

1Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2009
Grant dateDec 30, 2014
Priority date—
Expiry dateDec 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.